Update cookies preferences

E-book: Antiarrhythmic Drugs

Edited by , Edited by , Edited by
  • Format: PDF+DRM
  • Pub. Date: 17-Feb-2025
  • Publisher: Springer International Publishing AG
  • Language: eng
  • ISBN-13: 9783031740466
  • Format - PDF+DRM
  • Price: 148,19 €*
  • * the price is final i.e. no additional discount will apply
  • Add to basket
  • Add to Wishlist
  • This ebook is for personal use only. E-Books are non-refundable.
  • Format: PDF+DRM
  • Pub. Date: 17-Feb-2025
  • Publisher: Springer International Publishing AG
  • Language: eng
  • ISBN-13: 9783031740466

DRM restrictions

  • Copying (copy/paste):

    not allowed

  • Printing:

    not allowed

  • Usage:

    Digital Rights Management (DRM)
    The publisher has supplied this book in encrypted form, which means that you need to install free software in order to unlock and read it.  To read this e-book you have to create Adobe ID More info here. Ebook can be read and downloaded up to 6 devices (single user with the same Adobe ID).

    Required software
    To read this ebook on a mobile device (phone or tablet) you'll need to install this free app: PocketBook Reader (iOS / Android)

    To download and read this eBook on a PC or Mac you need Adobe Digital Editions (This is a free app specially developed for eBooks. It's not the same as Adobe Reader, which you probably already have on your computer.)

    You can't read this ebook with Amazon Kindle

This extensively updated edition reviews current and potential future therapies for cardiac arrhythmias. Developing the highly practical format of the original, this edition provides a thorough guide for the use of pharmaceuticals in the management of the condition and is focused on providing a clinical manual for arrhythmia treatment.

Antiarrhythmic Drugs builds on the current understanding of pathophysiological mechanisms and insights gained from previous studies of therapeutic interventions. It is designed to establish the baseline level of knowledge that a cardiovascular professional needs to know on a day-to-day basis.

Introduction: Cardiac arrhythmias a clinical problem.- Electrophysiological basis of the arrhythmias.- Class I antiarrhythmic drugs (Na+ channel blockers).- Potassium-channel blockers.- Betablockers.- Modulation of calcium handling/Calcium-channel modulators.- Other antiarrhythmic drugs: Novel targets for AADs.- Non-antiarrhythmic drugs with antiarrhythmic effects.- Clinical management of the arrhythmias.
A Martinez Rubio, is Chief of the Cardiology Department at the University Hospital of Sabadell and professor of Medicine at the Universitat Autònoma of Barcelona, Spain. Ex-president of the International Society of Cardiovascular Pharmacotherapy









J Tamargo is professor of Pharmacology at the School of Medicine of the Univ. Complutense of Madrid, Spain





 





G.-Andrei Dan is Distinguished/Emeritus Professor of Cardiology & Internal Medicine  at the Carol Davila University of Medicine,  Honorary Member of the Romanian Academy of Scientists and past President of ISCP. Profesor Dan' main expertise is electrophysiology, pharmacology of antiarrhythmic drugs, atrial fibrillation and heart failure. He wrote more than 170 scientific papers, presented more than 50 international conferences and contributed to 15 European guidelines. He is a member of the board of several prestigious medical journals, Deputy Editor of the American Journal of Therapeutics and Editor in Chief of the Romanian Journal of Internal Medicine. He is also an Honorary Citizen of the Romanian capital, Bucharest